| Name | Title | Contact Details |
|---|
Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world`s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised more than $1 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.
Pagemill Partners, LLC is a Palo Alto, CA-based company in the Financial Services sector.
Nippon Fusso USA is a Hayward, CA-based company in the Financial Services sector.
Maxgain is a San Mateo, CA-based company in the Financial Services sector.
Founded in 2008, Lincoln Peak Capital is a long-term, supportive equity partner to entrepreneurial management teams of high-quality asset management firms. Leveraging its deep industry experience and proven value-add approach, Lincoln Peak provides capital and expertise to help its partner firms successfully transition ownership and enhance their core capabilities. Since inception, Lincoln Peak has invested in category-leading asset management firms that collectively manage more than $100 billion.